Market revenue in 2022 | USD 2,417.6 million |
Market revenue in 2030 | USD 4,121.7 million |
Growth rate | 6.9% (CAGR from 2022 to 2030) |
Largest segment | Oxygen delivery devices |
Fastest growing segment | Oxygen Delivery Devices |
Historical data | 2018 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Oxygen Source Equipment, Oxygen Delivery Devices |
Key market players worldwide | GE HealthCare Technologies Inc Common Stock, Inogen Inc, Smiths Group PLC, Fisher & Paykel Healthcare Corp Ltd, Koninklijke Philips NV, Allied Healthcare Products Inc, Teleflex Inc, Chart Industries Inc, Draegerwerk AG & Co KGaA, Niterra Co Ltd, Invacare, Hersill, DeVilbiss Healthcare, Tecno-Gaz |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to oxygen therapy market will help companies and investors design strategic landscapes.
Oxygen delivery devices was the largest segment with a revenue share of 50.69% in 2022. Horizon Databook has segmented the China oxygen therapy market based on oxygen source equipment, oxygen delivery devices covering the revenue growth of each sub-segment from 2018 to 2030.
The high prevalence of respiratory diseases in China is a major factor driving growth. The increase in adoption of home care, technological advancements, and ongoing economic & demographic trends are the major factors contributing to growth of the market in China.
Chronic respiratory diseases are the second-leading cause of death in China. According to WHO, it is estimated that over half of adult Chinese men smoke. The biggest risk factor for this disease is cigarette smoking and air pollution.
Thus, there are public health initiatives in China to reduce respiratory diseases that cause death. Hence, all these factors are expected to drive growth of the oxygen therapy market in China. Furthermore, the companies are implementing certain strategic initiatives.
Horizon Databook provides a detailed overview of country-level data and insights on the China oxygen therapy market , including forecasts for subscribers. This country databook contains high-level insights into China oxygen therapy market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account